Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
155.6 USD | +0.53% | +2.12% | -5.88% |
Composition of VanEck Biotech ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
---|---|---|---|---|---|---|
270 USD | +0.22% | +0.39% | -6.26% | 19.50% | ||
397.5 USD | -0.06% | +0.81% | -2.31% | 11.25% | ||
65.42 USD | +0.23% | -2.01% | -19.24% | 9.94% | ||
883.2 USD | -0.84% | -1.52% | +0.56% | 8.97% | ||
108 USD | +1.69% | +6.47% | +8.57% | 5.32% | ||
234.9 USD | +0.38% | +2.98% | +1.51% | 4.71% | ||
208.9 USD | +3.18% | +7.47% | -19.27% | 4.58% | ||
308.3 USD | +2.74% | +6.97% | +8.92% | 4.00% | ||
122.3 USD | +1.02% | +4.13% | -12.18% | 3.79% | ||
153.6 USD | +3.38% | +18.58% | -14.85% | 2.58% | ||
80.91 USD | -1.53% | -8.71% | -16.09% | 2.48% | ||
143.3 USD | -0.28% | -0.76% | -25.13% | 2.17% | ||
128.8 USD | +1.08% | +11.37% | +33.54% | 2.04% | ||
229 USD | +0.54% | +0.99% | -3.12% | 1.97% | ||
87.21 USD | +0.58% | +0.46% | -17.37% | 1.97% | ||
64.06 USD | +2.23% | +3.12% | -16.98% | 1.90% | ||
58.85 USD | +0.10% | -3.46% | -20.45% | 1.82% | ||
41.65 USD | +1.39% | +4.12% | -6.98% | 1.75% | ||
166.6 USD | +0.56% | +6.01% | -7.35% | 1.69% | ||
51.68 USD | +0.98% | -1.28% | -17.69% | 1.64% | ||
91.66 USD | +0.42% | +7.48% | +46.33% | 1.36% | ||
53.91 USD | +0.34% | -2.07% | -13.88% | 0.89% | ||
Description
US92189F7261 | |
---|---|
Total Expense Ratio | 0.35% |
Asset Class | |
Sector | |
Size | |
Currency | |
Provider | |
Underlying | MVIS US Listed Biotech 25 Net Total Return Index - USD |
Features and characteristics
Jurisdiction | |
Fund Structure | |
Replication Method | |
Replication Model | |
Date of creation |
20/12/2011
|
Dividend Policy | |
Geographical Focus |
AuM evolution ( 28/03/2024 )
AuM (EUR) | 419 M€ |
---|---|
AuM 1M | 424 M€ |
AuM 3 months | 444 M€ |
AuM 6 months | 427 M€ |
AuM 12 months | 450 M€ |
- Stock Market
- ETF
- BBH ETF
- Components VanEck Biotech ETF - USD